Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Arcturus: Potential Based On Rare Disease Therapy ARCT-810 [Seeking Alpha]

Arcturus Therapeutics Holdings Inc. (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
Company Research Source: Seeking Alpha
gorodenkoff/iStock via Getty ImagesArcturus Therapeutics Holdings Inc.NASDAQ:ARCTa rare disease known as ornithine transcarbamylase (OTC) deficiency. It is gearing up to dose the first patient in mid-2022 with interim results from the study expected in the 2nd half of 2022. Not only that, but it has shown that its two-dose vaccination of 5 mcg doses of ARCT-154 COVID-19 vaccine as effective in reducing severe (fatal) disease by 95%. The data generated from this has been submitted for Emergency Use Authorization (EUA) in Vietnam April 13 of 2022. If all goes accordingly, then it will receive EUA in Vietnam for ARCT-154. Not only that, but it released 3-month booster data for ARCT-154 in May of 2022. Based on all these factors, these are the reasons why I believe that Arcturus is a great speculative biotech play to look into.EUA for ARCT-154 Submitted To VietnamArcturus established proof of concept in its phase 1/2/3 registrational study for Vietnam. It recruited a total of 19,000 adult Show less Read more
Impact Snapshot
Event Time:
ARCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ARCT alerts
Opt-in for
ARCT alerts

from News Quantified
Opt-in for
ARCT alerts

from News Quantified